Brief: Enlivex Receives Israeli Ministry Of Health Authorization For The Initiation Of A Phase I/Ii Trial Evaluating Allocetra Combined With Chemotherapy
06/06/2022 14:10
June 6 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX RECEIVES ISRAELI MINISTRY OF HEALTH AUTHORIZATION
FOR
THE INITIATION OF A PHASE I/II TRIAL EVALUATING ALLOCETRA
COMBINED WITH CHEMOTHERAPY IN PATIENTS WITH PERITONEAL
METASTASES ARISING FROM SOLID CANCERS
Source text for Eikon: ID:nGNX9qd3hd
Further company coverage: ENLV.TA
((reuters.briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment